Seasonal flu epidemic in the Netherlands The flu epidemic in the Netherlands has started. The number of people with flu (influenza) increased significantly in the past two weeks.
Flu epidemic seems to be emerging More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.
Significant increase in support for and compliance with coronavirus measures Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms increased during the recent period of high infection rates and hospital admissions.
Wider availability of self-tests leads to higher willingness to test As of Friday 3 December, the recommendation in the Netherlands is to use a self-test in case of mild symptoms, as an alternative to a test by the Municipal Public Health Services (GGDs). Beeld: ANP
Compliance with coronavirus measures requires attention Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms decreased in the weeks leading up to the Cabinet’s recent press conference.
More than health risks play a role in compliance with coronavirus measures The risk of COVID-19 is not the only factor that determines compliance with the coronavirus measures; other risks also play a role.
Flu jab for additional groups The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons
Policy on coronavirus measures causes friction, but compliance is still high for now Compliance with the coronavirus measures in the Netherlands, such as the night-time curfew, working from home and avoiding crowds, is still high.
Last winter’s flu epidemic was short and mild. And then COVID-19 arrived. The flu epidemic in the winter of 2019/2020 was mild and lasted only 5 weeks.
Compliance with coronavirus measures has improved Autumn 2020 saw a strong surge in the number of people who tested positive for COVID-19.